For example, it is known that inhibition of topoisomerase 1 (TOP1) leads to an increase in the formation of readthrough transcripts, while TOP1 inhibitors, irinotecan and topotecan, are widely used in the treatment of colorectal, pancreatic, ovarian, and lung cancers [57,58,59,60,61]. The gene discussed is TOP1; the disease is lung cancer.